This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
$259.00 per year
only $21.58 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
References
Jagasia MH, Greinix HT, Arora M, Williams KM, Wolff D, Cowen EW, et al. National Institutes of Health Consensus Development Project on Criteria for Clinical Trials in Chronic Graft-versus-Host Disease: I. The 2014 Diagnosis and Staging Working Group Report. Biol Blood Marrow Transplant. 2015;21:389–401.
Ghosh A, Coondoo A. Lichen planus pigmentosus: the controversial consensus. Indian J Dermatol. 2016;61:482–6.
Sehgal VN, Verma P, Bhattacharya SN, Sharma S, Rasool F. Lichen planus pigmentosus. Skinmed. 2013;11:96–103.
Del Pozo J, Garcia-Silva J, Yebra-Pimentel MT. Chronic graft-versus-host disease presenting as bullous lesions. Actas Dermosifiliogr. 2008;99:803–7.
Weinberg JL, Rosenbach M, Kim EJ, Kovarik CL. Lichen sclerosus et atrophicus-like graft-versus-host disease post stem cell transplant. Dermatol Online J. 2009;15:4.
Wolff D, Schleuning M, von Harsdorf S, Bacher U, Gerbitz A, Stadler M, et al. Consensus conference on clinical practice in chronic GVHD: second-line treatment of chronic graft-versus-host disease. Biol Blood Marrow Transplant. 2011;17:1–17.
Verma P, Pandhi D. Topical tacrolimus and oral dapsone combination regimen in lichen planus pigmentosus. Skinmed. 2015;13:351–4.
Muthu SK, Narang T, Saikia UN, Kanwar AJ, Parsad D, Dogra S. Low-dose oral isotretinoin therapy in lichen planus pigmentosus: an open-label non-randomized prospective pilot study. Int J Dermatol. 2016;55:1048–54.
Shulman HM, Cardona DM, Greenson JK, Hingorani S, Horn T, Huber E, et al. NIH Consensus Development Project on Criteria for Clinical Trials in Chronic Graft-versus-Host Disease: II. The 2014 Pathology Working Group Report. Biol Blood Marrow Transplant. 2015;21:589–603.
Creamer D, Martyn-Simmons CL, Osborne G, Kenyon M, Salisbury JR, et al. Eczematoid graft-vs-host disease: a novel form of chronic cutaneous graft-vs-host disease and its response to psoralen–UV-A therapy. Arch Dermatol. 2007;143:1157–62.
Al-Mutairi N, El-Khalawany M. Clinicopathological characteristics of lichen planus pigmentosus and its response to tacrolimus ointment: an open label, non-randomized, prospective study. J Eur Acad Dermatol Venereol. 2010;24:535–40.
Tschen JA, Tschen EA, McGavran MH. Erythema dyschromicum perstans. J Am AcadDermatol. 1980;2:295–302.
Berger RS, Hayes TJ, Dixon SL. Erythema dyschromicum perstans and lichen planus: are they related? J Am Acad Dermatol. 1989;21(2 Pt 2):438–42.
Robles-Méndez JC, Rizo-Frías P, Herz-Ruelas ME, Pandya AG, Ocampo Candiani J. Lichen planus pigmentosus and its variants: review and update. Int J Dermatol. 2017. https://doi.org/10.1111/ijd.13806. [Epub ahead of print].
Aractingi S, Janin A, Devergie A, Bourges M, Socie G, Gluckman E. Histochemical and ultrastructural study of diffuse melanoderma after bone marrow transplantation. Br J Dermatol. 1996;134:325–31.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflict of interest
The authors declare that they have no conflict of interest.
Additional information
Gérard Socié and Jean-David Bouaziz contributed equally to this work.
Electronic supplementary material
Rights and permissions
About this article
Cite this article
Tétu, P., Jachiet, M., de Masson, A. et al. Chronic graft versus host disease presenting as lichen planus pigmentosus. Bone Marrow Transplant 53, 1048–1050 (2018). https://doi.org/10.1038/s41409-018-0110-z
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1038/s41409-018-0110-z